Lp(a) Screening Recommended in Intermediate and High CV Risk Groups

MedWire News: The European Atherosclerosis Society Consensus Panel is recommending that patients at intermediate or high risk for cardiovascular disease (CVD) should be screened for elevated levels of lipoprotein (Lp)(a).